✦ LIBER ✦

Cost-effectiveness analysis of micafungin versus caspofungin for treatment of systemic Candida infections in the UK

✍ Scribed by Sidhu, M. K.; van Engen, A. K.; Kleintjens, J.; Schoeman, O.; Palazzo, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN44 A COST-EFFECTIVENESS ANALYSIS OF M

✍ Sidhu, MK; Van Engen, AK; Switjnk, AB; Concia, E 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PIN50 MICAFUNGIN VS CASPOFUNGIN FOR THE

✍ Felder, S; Grabe, K; Mayrhofer, T; Decker, S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

PIN16 COST-EFFECTIVENESS ANALYSIS OF MIC

✍ A Odeyemi; WM Hart; II Odeyemi; P Musingarimi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PIN3 ECONOMIC ANALYSIS OF MICAFUNGIN VER

✍ K Schaffer; M Schaefer; RS Schaefer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

A cost-effectiveness analysis of caspofu

✍ Karin Bruynesteyn; Vanya Gant; Catherine McKenzie; Tony Pagliuca; Chris Poynton; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

PIN77 Cost Effectiveness of De-Escalatio

✍ R. Masterton; M. Casamayor; P. Musingarimi; A. Van Engen; O. Odufowora-Sita 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB